Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsWith over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications. Highlights
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsAs one of the first-in-class global manufacturers of antibodies, Creative Biolabs is professional in producing all kinds of reagent and therapeutic antibodies. Based on our advanced techniques and rich experience, we have developed and optimized a novel phage display platform for antibody production. In particular, our professional scientists are confident in screening novel antibodies against coronavirus using our premade phage displayed human antibody library.
Since the emergence of the 2019 novel coronavirus (COVID-19) infection in December 2019, it has rapidly spread across all over the world. So far, the COVID-19 has affected more than ten million patients and became a major global health concern. During the past months, much work has focused on the development of novel vaccines and treatments for COVID-19. Antibodies isolated from the blood of people who have recovered from COVID-19 have been treated as a specific treatment to recognize and bind to the spike protein of coronavirus particles and thus hopefully block the virus from infecting human cells. Besides, the structure and function of different antibodies are under investigation to promote the development of vaccines.
Currently, premade human antibody screening has been treated as a powerful solution for the development of various therapeutic/diagnostic antibodies. Based on extensive experience and advanced phage display technology, Creative Biolabs has integrated a comprehensive portfolio of premade phage display libraries to help global researchers screen novel antibodies against specific targets. Our professional scientists are confident in tailoring the most appropriate biopanning strategy to promote the development of your programs. Premade phage displayed antibody libraries available at Creative Biolabs:
| Libraries | Library ID | Display Technology | Library Format | Species | Library Size |
| Phage display human scFv libraries | HuScL-2 | Phage Display | scFv | Human | 1.42×109 |
| HuScL-4 | Phage Display | scFv | Human | 2.0×109 | |
| HuScL-6 | Phage Display | scFv | Human | 1.0×1011 | |
| HuScL-7 | Phage Display | scFv | Human | 1.1×1010 | |
| HuScL-2S | Phage Display | scFv | Human | 2.36×1010 | |
| Phage display human Fab libraries | HuFabL-4 | Phage Display | Fab | Human | 1.9×1010 |
| HuFabL-5 | Phage Display | Fab | Human | 1.1×1010 | |
| HuFabssL-1 | Phage Display | Fab | Human | 1.8×1010 |
Creative Biolabs also provides antibody discovery services for different types of targets to suit a variety of applications:
Creative Biolabs is a well-recognized leader in the field of premade antibody library screening. Based on our advanced phage display technology, our scientists are specialized in the production and discovery of specific binders against numerous antigens. We are happy to offer high-quality customized services by adjusting protocols to meet even the most specific requirements. To learn more about how we can aid your project, please feel free to contact us.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
